Literature DB >> 28775604

MAGNETIC RESONANCE IMAGING IN FAILED BACK SURGERY SYNDROME.

K K Sen1, Amarjit Singh2.   

Abstract

The failed back surgery syndrome (FBSS) is a severe, long-lasting, disabling and relatively frequent (5-10%) complication of lumbosacral spine surgery. Wrong level surgery, inadequate surgical techniques, vertebral instability, recurrent disc herniation, and lumbosacral fibrosis are the most frequent causes of FBSS. The results after repeated surgery on recurrent disc herniations are comparable to those after the first intervention, whereas repeated surgery for fibrosis gives only 30-35% success rates, and 15-20% of the patients report worsening of the symptoms. MRI has allowed a differentiation between these two pathologies for selection of different therapies. Gadolinium enhanced MR is at present the single most sensitive and specific imaging modality available to the neuro radiology imager for the evaluation of the post operative lumbosacral spine in the patient presenting with FBSS. Medical imaging specialists and clinicians need to better understand the origins and means of avoiding the FBSS, to more clearly focus the post operative imaging evaluation and to more successfully link the clinical diagnosis and the imaging findings with optimised patient therapy.

Entities:  

Keywords:  Back pain; Failed back surgery syndrome; Gadolinium; Magnetic Resonance Imaging

Year:  2017        PMID: 28775604      PMCID: PMC5531858          DOI: 10.1016/S0377-1237(17)30269-1

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  19 in total

Review 1.  Spondylolysis, spondylolisthesis, and associated nerve root entrapment in the lumbosacral spine: MR evaluation.

Authors:  J R Jinkins; J C Matthes; R N Sener; S Venkatappan; R Rauch
Journal:  AJR Am J Roentgenol       Date:  1992-10       Impact factor: 3.959

2.  Contrast-enhanced MR imaging performed after successful lumbar disk surgery: prospective study.

Authors:  S D Boden; D O Davis; T S Dina; C P Parker; S O'Malley; J L Sunner; S W Wiesel
Journal:  Radiology       Date:  1992-01       Impact factor: 11.105

3.  Scanning electron microscopy of normal human scar tissue and keloids.

Authors:  J A Hunter; J B Finlay
Journal:  Br J Surg       Date:  1976-10       Impact factor: 6.939

4.  Gadolinium-DTPA-enhanced MR imaging of the postoperative lumbar spine: time course and mechanism of enhancement.

Authors:  J S Ross; R Delamarter; M G Hueftle; T J Masaryk; M Aikawa; J Carter; C VanDyke; M T Modic
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

5.  MR imaging of the postoperative lumbar spine: assessment with gadopentetate dimeglumine.

Authors:  J S Ross; T J Masaryk; M Schrader; A Gentili; H Bohlman; M T Modic
Journal:  AJR Am J Roentgenol       Date:  1990-10       Impact factor: 3.959

6.  Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.

Authors:  S A Mirowitz; K L Shady
Journal:  AJR Am J Roentgenol       Date:  1992-08       Impact factor: 3.959

7.  Contrast enhancement in spinal MR imaging.

Authors:  R K Breger; A L Williams; D L Daniels; L F Czervionke; L P Mark; V M Haughton; R A Papke; M Coffer
Journal:  AJR Am J Roentgenol       Date:  1989-08       Impact factor: 3.959

8.  The postoperative myelogram. Radiographic evaluation of arachnoiditis and dural/arachnoidal tears.

Authors:  R M Quencer; M Tenner; L Rothman
Journal:  Radiology       Date:  1977-06       Impact factor: 11.105

9.  Diagnosis of lumbar spinal stenosis in adults: a metaanalysis of the accuracy of CT, MR, and myelography.

Authors:  D L Kent; D R Haynor; E B Larson; R A Deyo
Journal:  AJR Am J Roentgenol       Date:  1992-05       Impact factor: 3.959

10.  Intravenous contrast-enhanced CT of the postoperative lumbar spine: improved identification of recurrent disk herniation, scar, arachnoiditis, and diskitis.

Authors:  J G Teplick; M E Haskin
Journal:  AJR Am J Roentgenol       Date:  1984-10       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.